"As of Friday, August 13, 2021 Diablo Valley Oncology, Pacific Urology and West Coast Surgical Associates will join John Muir Health, a nationally recognized non-profit, community-based health system whose mission is to serve its communities with quality and compassion. We are excited to become part of the John Muir Health family and we look forward to continuing to provide you with the high-level of care and service you deserve. For ongoing updates and information about COVID-19, including how to access care, please visit the John Muir Health website."

During the past decade, John Muir/Mt. Diablo Comprehensive Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 12 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Muir/Mt. Diablo Comprehensive Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 6 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Telik" with 4 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Muir/Mt. Diablo Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "John Muir/Mt. Diablo Comprehensive Cancer Center" are "Breast Cancer" (6 trials), "Lung Cancer" (5 trials), "Colorectal Cancer" (3 trials), "Metastatic Cancer" (3 trials) and "Ovarian Neoplasms" (3 trials). Many other conditions were trialed in "John Muir/Mt. Diablo Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "John Muir/Mt. Diablo Comprehensive Cancer Center" are "Drug" (21 trials), "Other" (11 trials), "Radiation" (10 trials), "Procedure" (9 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Letrozole" (3 trials), "radiation therapy" (3 trials), "Laboratory Biomarker Analysis" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "John Muir/Mt. Diablo Comprehensive Cancer Center" are 16 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "John Muir/Mt. Diablo Comprehensive Cancer Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in John Muir/Mt. Diablo Comprehensive Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in John Muir/Mt. Diablo Comprehensive Cancer Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".